The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) seeks to discover which biomarkers, cognitive characteristics, and health and lifestyle factors determine the development of AD.
Although AIBL and ADNI have many of the same goals, there are differences between the two projects. Read more about the AIBL study from their website.
Study Participants
AIBL has enrolled 1100 participants and collected over 4.5 years worth of longitudinal data.
- 211 AD patients
- 133 MCI patients
- 768 comparable healthy controls
Data
AIBL follows ADNI 1 protocols. Available data includes:
- Clinical and cognitive data
- Image data: MRI, PET
- Biomarkers data: blood, genotype, ApoE
- Dietary/lifestyle assessment
More information about AIBL study data can be found here.
